170 related articles for article (PubMed ID: 32128167)
1. Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy.
Morana P; Mucci F; Baroni S; Della Vecchia A; Piccinni A; Morana B; Marazziti D
Clin Case Rep; 2020 Feb; 8(2):254-257. PubMed ID: 32128167
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder.
Chen CK; Shiah IS; Yeh CB; Mao WC; Chang CC
Clin Neuropharmacol; 2005; 28(3):136-8. PubMed ID: 15965313
[TBL] [Abstract][Full Text] [Related]
4. Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder.
Malek-Ahmadi P; Hanretta AT
Ann Pharmacother; 2004 Nov; 38(11):1852-4. PubMed ID: 15479776
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
[TBL] [Abstract][Full Text] [Related]
6. Oxcarbazepine treatment of bipolar disorder.
Ghaemi SN; Berv DA; Klugman J; Rosenquist KJ; Hsu DJ
J Clin Psychiatry; 2003 Aug; 64(8):943-5. PubMed ID: 12927010
[TBL] [Abstract][Full Text] [Related]
7. Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports.
Wilkowska A; Wiglusz MS; Cubała WJ
Front Psychiatry; 2019; 10():520. PubMed ID: 31379632
[TBL] [Abstract][Full Text] [Related]
8. The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
Bastiampillai TJ; Reid CE; Dhillon R
J Psychopharmacol; 2010 Dec; 24(12):1834-6. PubMed ID: 20142304
[TBL] [Abstract][Full Text] [Related]
9. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder.
Galova A; Berney P; Desmeules J; Sergentanis I; Besson M
BMC Psychiatry; 2019 Feb; 19(1):73. PubMed ID: 30782143
[TBL] [Abstract][Full Text] [Related]
10. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
Diraoui S; van Melick EJ; Jansen PA
Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
[TBL] [Abstract][Full Text] [Related]
11. [Behavior disturbances in emergency psychiatry or fronto-temporal dementia diagnosis? A challenge for psychiatrists].
Gigi A; Pirrotta R; Kelley-Puskas M; Lazignac C; Damsa C
Encephale; 2006 Oct; 32(5 Pt 1):775-80. PubMed ID: 17099602
[TBL] [Abstract][Full Text] [Related]
12. Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine.
Merizalde M; Navalón P; González MF; Domínguez A; Livianos L; Martínez JC
J Affect Disord; 2017 Mar; 210():122-124. PubMed ID: 28027511
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine in the treatment of refractory rapid cycling bipolar disorder].
Lançon C; Llorca PM
Encephale; 1996; 22(6):468-9. PubMed ID: 10901840
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine in the maintenance treatment of bipolar disorder.
Vasudev A; Macritchie K; Watson S; Geddes JR; Young AH
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005171. PubMed ID: 18254071
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine in bipolar disorder: a critical review of the literature.
Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
[TBL] [Abstract][Full Text] [Related]
16. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
17. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ
Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine-induced dystonia.
Pavlis CJ; Kutscher EC; Carnahan RM; Kennedy WK; Van Gerpen S; Schlenker E
Am J Health Syst Pharm; 2007 Dec; 64(23):2468-70. PubMed ID: 18029952
[TBL] [Abstract][Full Text] [Related]
20. The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders.
Chang JS; Ha KS; Young Lee K; Sik Kim Y; Min Ahn Y
J Clin Psychiatry; 2006 Mar; 67(3):461-7. PubMed ID: 16649834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
